
Bliss GVS Pharma Share Price
₹131.53 -5.92 (-4.31%)
16 Feb, 2025 18:33
Start SIP in
BLISSGVS
Performance
- Low
- ₹129
- High
- ₹141
- 52 Week Low
- ₹92
- 52 Week High
- ₹186
- Open Price₹138
- Previous Close₹137
- Volume859,421
Investment Returns
- Over 1 Month -17.33%
- Over 3 Month + 11.45%
- Over 6 Month + 19.64%
- Over 1 Year + 11.56%
Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!
Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 23.2
- PEG Ratio
- -0.7
- Market Cap Cr
- 1,386
- P/B Ratio
- 1.4
- Average True Range
- 10.33
- EPS
- 7.63
- Dividend Yield
- 0.4
- MACD Signal
- -4.14
- RSI
- 36.19
- MFI
- 62.4
Bliss GVS Pharma Financials
Bliss GVS Pharma Technicals
EMA & SMA
Current Price
₹131.53
-5.92
(-4.31%)

-
- Bearish Moving Average 15
-
- Bullish Moving Average 1
- 20 Day
- ₹148.71
- 50 Day
- ₹152.19
- 100 Day
- ₹146.72
- 200 Day
- ₹136.20
Resistance and Support
133.7
- R3 151.30
- R2 146.16
- R1 138.84
- S1 126.38
- S2 121.24
- S3 113.92
Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-28 | Quarterly Results & Others | To consider other business matters. per share(50%)Dividend |
2024-10-24 | Quarterly Results | |
2024-07-24 | Quarterly Results | |
2024-05-02 | Audited Results & Final Dividend | |
2024-01-23 | Quarterly Results |
Bliss GVS Pharma F&O
About Bliss GVS Pharma
- NSE Symbol
- BLISSGVS
- BSE Symbol
- 506197
- Managing Director
- Mr. Gagan Harsh Sharma
- ISIN
- INE416D01022
Similar Stocks to Bliss GVS Pharma
Bliss GVS Pharma FAQs
Bliss GVS Pharma share price is ₹131 As on 16 February, 2025 | 18:19
The Market Cap of Bliss GVS Pharma is ₹1385.9 Cr As on 16 February, 2025 | 18:19
The P/E ratio of Bliss GVS Pharma is 23.2 As on 16 February, 2025 | 18:19
The PB ratio of Bliss GVS Pharma is 1.4 As on 16 February, 2025 | 18:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.